hrp0082p2-d1-564 | Sex Development | ESPE2014

46,XY Neonates and Infants with Ambiguous Genitalia: Who to Investigate?

Baetens Dorien , Mladenov Wilhelm , Chiaie Barbara Delle , Desloovere An , Iotova Violeta , Menten Bjorn , Van Laecke Eric , Hoebeke Piet , De Baere Elfride , Cools Martine

Background: Extensive and time-consuming hormonal and genetic work-up provides a genetic diagnosis in around 20% of 46,XY cases with ambiguous genitalia. It is currently unclear if such extensive screening might also be indicated in 46,XY newborns with milder undervirilization.Method: All 46,XY neonates and infants (n=32, EMS 2–12) referred to our pediatric endocrine service for atypical male genitalia in the period 2007–2013 were inve...

hrp0084fc8.4 | Obesity - Basic | ESPE2015

Severe Early-Onset Obesity Caused By Bioinactive Leptin due to a N103K Mutation

Wabitsch Martin , Funcke Jan-Bernd , von Schnurbein Julia , Denzer Friederike , Lahr Georgia , Denzer Christian , Moss Anja , Debatin Klaus-Michael , Gierschik Peter , Farooqi Sadaf , Moepps Barbara , Fischer-Posovszky Pamela

Background: Early-onset severe obesity due to leptin deficiency typically results from a defect of leptin production or secretion due to mutations in the leptin gene. Recently we described a new form of leptin deficiency caused by bioinactivity of the hormone and associated with high circulating leptin levels (New England Journal of Medicine 2015 372 48–54).Method: Serum leptin was measured by ELISA. The leptin gene was seq...

hrp0084p1-73 | Fat | ESPE2015

Circulating miR146a and 486-5p are Altered in Obese Children with and Without Non-Alcoholic Fatty Liver Disease (NAFLD) and Correlate with Abdominal Fat and BMI

Montanini Luisa , Patianna Viviana D , Sartori Chiara , Predieri Barbara , Bruzzi Patrizia , Lazzeroni Pietro , Merli Silvia , Bergamaschi Paolo , Bernasconi Sergio , Iughetti Lorenzo , Street Maria Elisabeth

Background: MicroRNAs (miRNA) are small non coding RNA molecules, key regulators of metabolic pathways. Obesity is characterised by many metabolic changes. NAFLD is seen as a complication of obesity. FOXO-1, key regulator in insulin signalling, has been shown to be implicated in NAFLD. We previously identified miRNAs regulators of the FOXO-1 gene.Objective and hypotheses: To assess in serum whether the regulation of miR-146a and miR-486-5p, FOXO1 gene re...

hrp0094p2-475 | Thyroid | ESPE2021

Case study of 13- year-old boy suffering from papillary thyroid cancer in stage pT3aN1bMX

Bossowski Artur , Borysewicz-Sanczyk Hanna , Stożek Karolina , Dzięcioł Janusz , Czarniecka Agnieszka , Handkiewicz-Junak Daria , Jarząb Barbara

Papillary cancer represents majority of thyroid malignancies in children. However prognosis remains very successful. In recent years, we use elastography, except biopsy and standard ultrasonography in thyroid lesions diagnostic. We present a case of a male patient at the age of 13 years, with a history of ADHD and school phobia who was referred to Endocrinology Outpatient Clinic due to partial empty sella syndrome. Family history of endocrinological disorders was negative. Ph...

hrp0098p1-194 | Sex Endocrinology and Gonads 2 | ESPE2024

Consequences for treatment following the German Act on the Protection of Children with Differences in Sexual Development (DSD)

Neumann Uta , Döhnert Ulla , Holterhus Paul-Martin , Wölfle Joachim , Wabitsch Martin , Eckoldt Felicitas , Ludwikowski Barbara , Binder Gerhard , Dunstheimer Désirée , Richter-Unruh Annette , Kamrath Clemens

Introduction: As of May 2021, German law protects children with differences of sex development (DSD), including females with congenital adrenal hyperplasia (CAH), from non-consensual genital surgery. Parents can consent only in emergencies; all other surgeries require the child's consent. Exceptions are allowed by law, with the approval of the family court following a positive decision by a multidisciplinary committee. If the family presents a positive de...

hrp0098p1-201 | Thyroid 2 | ESPE2024

Potential Role of Selected miRNAs in the Pathogenesis of Autoimmune Thyroid Diseases in Children and Adolescents

Sawicka Beata , Sulewska Anetta , Kulczyńska- Przybik Agnieszka , Bossowski Filip , Dulewicz Maciej , Borysewicz-Sańczyk Hanna , Mroczko Barbara , Niklinski Jacek , Bossowski Artur

Background: Many epigenetic factors, including microRNAs, are involved in the process of changing gene expression. MiRNAs are small non-coding RNA molecules that regulate gene translation by silencing or degrading target mRNAs. They are recognized as novel diagnostic and prognostic biomarkers for many diseases. Patients with autoimmune thyroid diseases are more likely to develop nodules in the thyroid tissue, and Hashimoto's thyroiditis and Graves’ ...

hrp0098p1-208 | Adrenals and HPA Axis 3 | ESPE2024

The prevalence of nephrocalcinosis among patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency – one-centre experience. Do we need a regular screening?

Banaszak-Ziemska Magdalena , Małecka Elżbieta , Obara-Moszyńska Monika , Rabska-Pietrzak Barbara , Flader Maciej , Słomko-Jóźwiak Małgorzata , Niedziela Marek

Introduction: In the literature, there are reports about nephrocalcinosis (NC), hypercalcemia, and hypercalciuria risk in patients with congenital adrenal hyperplasia (CAH). The prevalence and background of nephrocalcinosis is not established. Nephrocalcinosis refers to diffuse calcification in the renal parenchyma, generally in renal pyramids.Aim of the study: The study aimed to evaluate the prevalence of nephrocalcinos...

hrp0098p1-283 | Sex Endocrinology and Gonads 3 | ESPE2024

Care in the first weeks after a suspected DSD diagnosis – results of the Empower-DSD information management program

Wechsung Katja , Marshall Louise , Jürgensen Martina , Wiegmann Sabine , Kalender Ute , Neumann Uta , Stöckigt Barbara , behalf of the Empower-DSD Study group on

Introduction: The suspected diagnosis of an intersex condition in a child often causes great uncertainties in families. Since these are rare diagnoses, families often do not receive timely and comprehensive information. The Empower-DSD information management defines a structured multidisciplinary care and information exchange for children and their caretakers in the first 8-12 weeks after a suspected DSD diagnosis.Methods:</stron...

hrp0098p3-269 | Thyroid | ESPE2024

The comorbidity of other autoimmune diseases in children with autoimmune thyroid diseases

Michalak Justyna , Jamiołkowska-Sztabkowska Milena , Sawicka Beata , Borysewicz- Sańczyk Hanna , Stożek Karolina , Głowińska- Olszewska Barbara , Bossowski Artur

Key words: autoimmune diseases, autoimmune thyroid disease, Hashimoto thyroiditis, Graves DiseaseIntroduction: Autoimmune diseases are significant and common health problem, which incidence in population increase. They affect 3- 5% of the general population, mainly females. The most common in children are: autoimmune thyroid disease (AITD) and type 1 diabetes mellitus (T1DM). AITD and T1DM are known from their prevalence...

hrp0095fc2.2 | Bone, Growth Plate and Mineral Metabolism | ESPE2022

Final heights in 398 patients with X-linked hypophosphatemia (XLH) over the last decades in France, a surrogate marker of improved disease management. Study of a large cohort of XLH patients born between 1950 and 2006.

Berkenou Jugurtha , Boros Emese , Amouroux Cyril , Bacchetta Justine , Briot Karine , Edouard Thomas , Gueorgieva Iva , Girerd Barbara , Kamenicky Peter , Lecoq Anne-Lise , Marquant Emeline , Mignot Brigitte , Porquet Bordes Valérie , Salles Jean-Pierre , Zhukouskaya Volha , Linglart Agnès , Rothenbuhler Anya

Introduction: XLH is caused by mutations in PHEX leading to increased FGF23 levels, phosphate wasting, and impaired endogenous calcitriol synthesis. Affected patients present with rickets and diminished growth velocity during childhood, and osteomalacia and short stature in adulthood. Adult height is linked with health within and across generations suggesting that adult height may be a potential tool for monitoring health conditions, e.g., XLH.<p ...